Jerald Simmons, MD
Sleep Medicine · Houston, TXNPI 1417045329
Payments from drug & device makers
Across 914 payments — averaging $1079.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$464K
- Takeda Pharmaceuticals U.S.A., Inc.$233K
- Alkermes, Inc.$143K
- Harmony Biosciences LLC$91K
- Avadel CNS Pharmaceuticals, LLC$26K
- Axsome Therapeutics, Inc.$14K
- plus $16K from 19 others
Across 4 payments — averaging $320.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$1K
What the payments were for
- Consulting fees$20,47812%
- Speaking & faculty fees$115,65070%
- Travel & lodging$19,17112%
- Food & beverage$9,8986%
- Education$1570%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 449 | $464,003 |
| Takeda Pharmaceuticals U.S.A., Inc. | 50 | $232,709 |
| Alkermes, Inc. | 121 | $142,773 |
| Harmony Biosciences LLC | 128 | $90,964 |
| Avadel CNS Pharmaceuticals, LLC | 49 | $26,296 |
| Axsome Therapeutics, Inc. | 10 | $13,733 |
| Merck | 9 | $9,847 |
| Inspire Medical Systems, Inc. | 58 | $3,915 |
| ZOLL Respicardia, Inc. | 5 | $1,619 |
| SK Life Science, Inc. | 13 | $248 |
| Resmed Corp | 4 | $91 |
| Livanova USA, Inc. | 3 | $63 |
| UCB, Inc. | 1 | $45 |
| Novartis | 2 | $34 |
| Biohaven Pharmaceuticals, Inc. | 2 | $33 |
| AbbVie | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| Noctrix Health, Inc. | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Itamar Medical Inc | 1 | $17 |
| Philips North America LLC | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XYREM$52,168
- Wakix$50,364
- LUMRYZ$25,648
- SUNOSI$13,631
- BELSOMRA$9,822
- Inspire Upper Airway Stimulation System$3,130
- XYWAV$2,335
- remede System$1,544
- Inspire$149
How this compares
$986,547 in reported general payments places this provider in the 95th percentile of 112 sleep medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylphenidate Hcl | 21 | $656 |
| Methadone Hcl | 13 | $52 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Houston
- Amit VermaHouston$522K
- Leon RosenthalHouston$6K
- Kevin LinHouston$4K
- Calli BertschyHouston$3K
- Annise WilsonHouston$2K
- Amita Shimpi BhallaHouston$2K
- Aparajitha VermaHouston$2K
- Cindy JonHouston$2K
- Meer AhmedHouston$2K
- Mauro Mendez BaylonHouston$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.